Plandaí Biotechnology Past Earnings Performance
Past criteria checks 0/6
There is insufficient data on Plandaí Biotechnology's performance over the last few years.
Key information
n/a
Earnings growth rate
n/a
EPS growth rate
Biotechs Industry Growth | 17.0% |
Revenue growth rate | n/a |
Return on equity | n/a |
Net Margin | n/a |
Last Earnings Update | 30 Sep 2016 |
Recent past performance updates
No updates
Recent updates
Revenue & Expenses Breakdown
How Plandaí Biotechnology makes and spends money. Based on latest reported earnings, on an LTM basis.
Earnings and Revenue History
Date | Revenue | Earnings | G+A Expenses | R&D Expenses |
---|---|---|---|---|
30 Sep 16 | 0 | -4 | 2 | 0 |
30 Jun 16 | 0 | -4 | 2 | 0 |
31 Mar 16 | 0 | -4 | 1 | 0 |
31 Dec 15 | 0 | -10 | 7 | 0 |
30 Sep 15 | 0 | -10 | 7 | 0 |
30 Jun 15 | 0 | -10 | 8 | 0 |
31 Mar 15 | 0 | -17 | 8 | 0 |
31 Dec 14 | 0 | -14 | 4 | 0 |
30 Sep 14 | 0 | -16 | 5 | 0 |
30 Jun 14 | 0 | -16 | 4 | 0 |
31 Mar 14 | 0 | -7 | 4 | 0 |
31 Dec 13 | 0 | -5 | 3 | 0 |
30 Sep 13 | 0 | -2 | 2 | 0 |
Quality Earnings: Insufficient data to determine if PLPL has high quality earnings.
Growing Profit Margin: Insufficient data to determine if PLPL's profit margins have improved over the past year.
Free Cash Flow vs Earnings Analysis
Past Earnings Growth Analysis
Earnings Trend: Insufficient data to determine if PLPL's year-on-year earnings growth rate was positive over the past 5 years.
Accelerating Growth: Insufficient data to compare PLPL's past year earnings growth to its 5-year average.
Earnings vs Industry: Insufficient data to determine if PLPL's earnings growth over the past year exceeded the Biotechs industry average.
Return on Equity
High ROE: PLPL has a negative Return on Equity (0%), as it is currently unprofitable.